D.C.’s Vanda Pharmaceuticals Inc. has locked in a deal with a West Coast biotech to commercialize a drug for a rare skin ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

To illustrate that point, let's discuss two stocks in the biotech industry that have moved in opposite directions so far this ...

Below is a condensed transcript of that exchange, in which Kennedy and Sanders spoke over each other and repeated themselves: ...

Top Republican recipients of contributions from employees or PACS associated with the pharmaceutical/health products ...

Japan’s ASKA Pharmaceutical Holdings announced it has decided to acquire additional shares of Vietnam-based Ha Tay ...

A quirk in the website OpenSecrets has given RFK Jr. a chance to misleadingly portray Sen. Bernie Sanders as receiving big ...

“Companies are realizing that investing stateside can provide more control and resilience to the drug supply chain,” says Dymowski. She cites political tensions, import and export disruptions, and ...

The global pharmaceutical industry is valued at approximately $1.6 trillion, while India's market stands at $55 billion, ...

January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

In this Pharmaceutical Executive video interview, Edoardo Madussi, Head of Business Development, Intelligencia AI discusses ...

Ultragenyx Pharmaceutical is a mid-cap biotech firm with a promising pipeline and an optimistic outlook from analysts. Click ...